Share price of Illinois-based Merge Healthcare Incorporated (MRGE), a developer of healthcare related imaging software solutions, rose 1.9% to eventually close at $3.25 yesterday following the recent launch of its Merge One cloud-based radiology solution, which will allow ambulatory radiology sites to boost their business.
Merge Healthcare will introduce the Merge One solution at the annual conference of the Radiology Society of North America (RSNA) to be held at Chicago from Nov 30 till Dec 5.
Merge One is a one-step solution that promises ambulatory imaging businesses a new way to strengthen their entire workflow at the lowest possible cost structure in the current competitive market. Merge Healthcare has developed the Merge One solution with support from ClearDATA – the healthcare industry leader in secure, HIPAA-compliant cloud computing.
Management at Merge Healthcare has expressed its concern regarding the consistent reimbursement pressures imaging centers have been facing from both Medicare and private payers. Cost worries thus rendered them incapable of upgrading their technology as they simply could not afford it.
Now with the launch of Merge One, management claims that imaging centers adopting this solution will not only be able to provide the latest technology to its customers in a cost-efficient manner, but will also stay a step ahead in the ever-changing competitive healthcare market.
By incorporating Merge One, imaging centers will no longer need to buy costly hardware and remain dependent on IT for ongoing support. This will help centers to provide test results for patients faster and with improved reliability.
We believe this state-of-the-art solution, apart from being profitable for Merge Healthcare, will also radically benefit the entire healthcare industry owing to its timely, cost-effective solutions that is expected to drive better patient outcome with improved access.
Zacks Rank
Currently, Merge Healthcare holds a Zacks Rank #2 (Buy). Some other well-placed stocks worth reckoning in the medical sector are Affymetrix Inc. (AFFX), AMAG Pharmaceuticals, Inc. (AMAG) and ANI Pharmaceuticals, Inc. (ANIP). All the three stocks sport a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
To read this article on Zacks.com click here.
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
Be the first to comment